Month: May 2022

Aemetis to Review First Quarter 2022 Financial Results on May 12, 2022

Written by Customer Service on May 9, 2022. Posted in Earnings Releases And Operating Results.

CUPERTINO, CA, May 09, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its first quarter 2022 earnings report: Date: Thursday, May 12, 2022 Time: 11 am Pacific Standard Time (PST) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 841388 Live Participant Dial In (International): +1-973-528-0011 entry code 841388 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/45517 Attendees may submit questions during the Q&A portion of the conference call. The webcast will be available on the Company’s website (www.aemetis.com) under Investors/Conference Calls, along with the company presentation, recent announcements and video recordings. The voice recording will be available through May 19, 2022 by dialing (Toll...

Alimera Sciences Reports First Quarter 2022 Results

Written by Customer Service on May 9, 2022. Posted in Earnings Releases And Operating Results.

Consolidated Net Revenue of $11.9 Million Up 6% vs. First Quarter of 2021 U.S. Net Revenue Increased 23% vs. First Quarter of 2021 U.S. End User Demand Up 25% vs. First Quarter of 2021ATLANTA, May 09, 2022 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announced financial results for the first quarter of 2022. Alimera will host a conference call on May 9th, 2022, at 9:00 a.m. ET to discuss these results and provide an update on corporate developments. “We are pleased with the continuing trend that we see in the U.S. market as we report another consecutive quarter of end user demand growth over the prior year period,” said Rick Eiswirth,...

Sabina Gold & Silver Announces Interim Financial Results for the Quarter Ended March 31, 2022

Written by Customer Service on May 9, 2022. Posted in Earnings Releases And Operating Results.

$221.4 million in cash and short-term investments VANCOUVER, British Columbia, May 09, 2022 (GLOBE NEWSWIRE) — Sabina Gold & Silver Corp. (“Sabina”) or (the “Company”) (SBB – TSX/ SGSVF – OTCQX) reports the interim financial results for the quarter ended March 31, 2022. “The first quarter culminated one of the most important milestones for the Company to date as we advance towards gold production,” said Bruce McLeod, the Company’s President & CEO. “Not only did we complete debt and streaming agreements on acceptable terms, but we also raised the equity component of our construction financing package. We believe Sabina truly stands apart among its peers as one of the only fully permitted, social licensed, engineered and financed projects in a tier one jurisdiction. We acknowledge our tremendous support in Nunavut...

Clene Reports First Quarter 2022 Financial Results and Recent Operating Highlights

Written by Customer Service on May 9, 2022. Posted in Earnings Releases And Operating Results.

Cash, cash equivalents, restricted cash and marketable securities of $36.6 million as of March 31, 2022 Additional data from RESCUE-ALS presented at 2022 AAN Annual Meeting and MDA Clinical & Scientific Conference; Results show significant survival benefit in participants who entered open-label extension study Top-line results from studies in ALS, MS and COVID-19 programs expected in third quarterSALT LAKE CITY, May 09, 2022 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, today reported its first quarter 2022 and recent operating highlights. “As we approach the second half of 2022, we expect to report data readouts for...

Compass Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress

Written by Customer Service on May 9, 2022. Posted in Earnings Releases And Operating Results.

The FDA cleared the investigational new drug application for CTX-009 (DLL4 X VEGF-A bispecific) in January allowing the Company to expand the ongoing Phase 2 study in patients with biliary tract cancer (BTC) to a global study and initiate dosing patients in the United States in early Q3 of 2022 The Company reported interim data from the ongoing Phase 2 study of CTX-009 and paclitaxel in patients with advanced BTC demonstrating a 42% overall response rate (ORR) and 92% clinical benefit rate (CBR) among the first 24 patients enrolled and dosed with interim median patient time on study of ~ 6 monthsThe Company completed enrollment in the CTX-471 (CD137 agonist) Phase 1b monotherapy study and reported 3 partial responses in patients with advanced solid tumors who were dosed with CTX-471 following progression on a prior PD-1/PD-L1 checkpoint...

Global Ship Lease Reports Results for the First Quarter of 2022

Written by Customer Service on May 9, 2022. Posted in Dividend Reports And Estimates.

Declares Dividend of $0.375 per Common Share LONDON, May 09, 2022 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE:GSL) (the “Company”, “Global Ship Lease” or “GSL”), an owner of containerships, announced today its unaudited results for the three months ended March 31, 2022. First Quarter 2022 – Reported operating revenue of $153.6 million for the first quarter 2022, 2.1 times revenue of $73.0 million for the prior year period. – Reported net income available to common shareholders of $70.2 million for the first quarter of 2022, an increase of 1,571.4% or 16.7 times net income of $4.2 million for the prior year period. Normalized net income(3) after $4.6 million positive fair value adjustment on derivatives, a prepayment fee of $4.0 million on the full repayment of our Blue Ocean Junior Credit Facility and the associated...

Locafy Exceeds $500k Monthly Revenue Milestone as Product Take-Up Accelerates

Written by Customer Service on May 9, 2022. Posted in Public Companies.

Key HighlightsLocafy achieved more than a $500,000 in revenue for the first time in April 2022, more than 130% YoY growth from April 2021 Locafy Reseller numbers more than tripled in the current financial year to now exceed 100 in April as the company continues its focus on growing its channel partner network in North America, UK and Australia Net new customer numbers continued to grow across channel and direct salesPERTH, AUSTRALIA, May 09, 2022 (GLOBE NEWSWIRE) — Operations Update Locafy had 103 Resellers at the end of April, more than 3.5x the number of Resellers at the start of the Australian financial year, which commenced July 1, 2021. Resellers are a key part of our plans to drive revenue growth. The onboarding of a large number in the last 11 months highlights the increasing interest and confidence around our product...

Emergia Inc. Announces Filing of Its 2021 Financial Statements

Written by Customer Service on May 9, 2022. Posted in Public Companies.

MONTREAL, May 09, 2022 (GLOBE NEWSWIRE) — (CSE: EMER) Emergia Inc. (the “Corporation” or “EMERGIA”) announces today that it has filed, its audited annual financial statements, ‎management’s discussion and analysis and its Annual Report, and related certifications for the fiscal year ended December ‎‎31, 2021. “Emergia has passed the crucial stages of its strategic restructuring plan implemented last year. Its thorough execution has resulted in a significant improvement in the Corporation’s balance sheet, particularly by its deleverage, and increase in the total assets value, as shown in the financial statements. These results thus prove the strength and soundness of our plan, which allowed to improve remarkably the financial situation of the Corporation compared to 2020” said Henri Petit, Chief Executive Officer of the Corporation. The...

Finch Therapeutics to Host Corporate Update Conference Call and Webcast on May 16, 2022

Written by Customer Service on May 9, 2022. Posted in Public Companies.

SOMERVILLE, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs, today announced it will host a conference call and live webcast on Monday, May 16, 2022 at 8:00am ET to discuss updates to its development programs and other business highlights. The conference call can be accessed by dialing (833) 649-1186 (domestic) or (270) 823-1080 (international) and entering conference ID 8451806. The live webcast can be accessed by visiting the ‘Investors & News’ section of the Finch Therapeutics website and selecting ‘Events & Presentations’. The webcast will be archived on the Finch website for approximately...

University of Tennessee Health Science Center Leverages CareCloud’s Technology to Enhance Revenues and Streamline Workflows

Written by Customer Service on May 9, 2022. Posted in Public Companies.

SOMERSET, N.J., May 09, 2022 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that the University of Tennessee Health Science Center, College of Dentistry Pathology, has selected CareCloud’s Revenue Cycle Services and talkEHR to enhance revenues, streamline workflows, and alleviate billing inefficiencies. The University of Tennessee is the seventh university specializing in oral pathology to select CareCloud’s cloud-based technology and the second university to select CareCloud this month. “We look forward to helping the University of Tennessee increase profitability with our digital, secure and flexible billing and EHR system,” said Al Nardi SVP Strategy, CareCloud. “The University evaluated a number...

Month: May 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals